News Stocks Vivimed Labs Shareholders Approve Pre-Packaged Insolvency Resolution Process with 99.70% MajorityVivimed Labs Shareholders Approve Pre-Packaged Insolvency Resolution Process with 99.70% Majority
Vivimed Labs Limited held an EGM on December 10, 2025, where shareholders approved a special resolution for pre-packaged insolvency resolution process with 99.70% majority. The e-voting process from December 7-9, 2025, saw participation from 92 shareholders casting over 2.11 crore votes in favor of the financial restructuring initiative.
*this image is generated using AI for illustrative purposes only.
Vivimed Labs Limited successfully conducted its Extraordinary General Meeting (EGM) on December 10, 2025, where shareholders voted on a critical special resolution regarding the company's financial restructuring. The meeting, held at 3:00 p.m. through video conferencing and other audio-visual means, addressed the application to initiate pre-packaged insolvency resolution process under the Insolvency and Bankruptcy Code, 2016.
Voting Results and Shareholder Participation
The special resolution received overwhelming support from shareholders, with detailed voting results demonstrating strong confidence in the proposed restructuring approach:
| Voting Category: | Details |
|---|---|
| Total Valid Votes: | 2,11,65,984 |
| Votes in Favor: | 2,11,65,984 (99.70%) |
| Votes Against: | 63,974 (0.30%) |
| Invalid Votes: | 0 |
The voting process included both remote e-voting and venue-based electronic voting. Remote e-voting attracted 76 shareholders who cast 2,11,53,107 votes, representing 99.64% of total valid votes. Additionally, 16 shareholders participated through venue e-voting at the EGM, contributing 12,877 votes.
E-Voting Process and Timeline
Vivimed Labs Limited provided comprehensive e-voting facilities to ensure maximum shareholder participation. The remote e-voting window remained open from 9:00 a.m. on December 7, 2025, until 5:00 p.m. on December 9, 2025. The company appointed Mr. N.V.S.S. Suryanarayana Rao, a practicing Company Secretary, as scrutinizer to oversee the entire voting process and ensure compliance with regulatory requirements.
Category-wise Voting Breakdown
The voting results showed strong support across different shareholder categories:
| Shareholder Category: | Votes Polled | Votes in Favor | Support (%) |
|---|---|---|---|
| Promoter and Promoter Group: | 53,14,290 | 53,14,290 | 100.00% |
| Public - Institutions: | 1,59,15,668 | 1,58,51,694 | 99.60% |
| Public - Non-Institutions: | 0 | 0 | 0.00% |
Notably, the promoter and promoter group demonstrated complete support for the resolution, while public institutions also showed strong backing with 99.60% votes in favor.
Regulatory Compliance and Documentation
The EGM was conducted in full compliance with Section 108 of the Companies Act, 2013, and Rule 20 of the Companies (Management and Administration) Rules, 2014. The company also adhered to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The scrutinizer submitted detailed reports on December 10, 2025, confirming the validity of the voting process and results.
Meeting Logistics and Record Date
The company set December 3, 2025, as the record date for determining eligible shareholders. As of this date, Vivimed Labs Limited had 49,959 total shareholders. The deemed venue for the EGM was the company's registered office at Plot No. 78/A, Kolhar Industrial Area, Bidar-585403, Karnataka, though the meeting was conducted entirely through digital means due to regulatory guidelines.
15
